Press & Media

Open Source Pharma Foundation in the News

Selected coverage of our work in scientific, business, and general-interest media — from vaccine research to open-source drug discovery.

Award

Fast Company World Changing Ideas Awards 2020

AI and Data — Finalist & Honorable Mention

Open Source Pharma Foundation receives honorable mention for its work harnessing the power of data, machine learning, or artificial intelligence to understand the world and empower change.

See the 2020 honorees

All Coverage

Every mention in one place — filter by articles, video, or community.

McKinsey & CompanyFebruary 2024

Are open source principles the key to saving lives?

Read Article
NewsweekSeptember 9, 2022

How COVID Opened a 'Pandora's Box' of Monkeypox, Polio and Other Diseases

Read Article
Medical supplies prepared for global health work
The New York Times
August 16, 2022

Why a Century-Old Vaccine Offers New Hope Against Pathogens

The century-old BCG tuberculosis vaccine, accessible to billions, trusted by billions, and which costs only 15 cents a dose, shows 92% efficacy against COVID-19 in very small clinical trial by Professor Denise Faustman of Harvard Medical School.

Read Article
Illustrated pathogen form
The New Yorker
February 8, 2022

Beyond the Booster Shot

In 2016, Jaykumar Menon, a human-rights lawyer based in New York, founded the Open Source Pharma Foundation to address market failures in drug development… One of its goals is to create new vaccines that leverage trained immunity for what it calls 'ultra-broad spectrum' coverage.

Read Article
NewsweekDecember 24, 2021

America's 50 Greatest Disruptors: Collaborative Tech to Develop New, Affordable Drugs – Open Pharma

Read Article
NDTVMay 31, 2021

Can Open-Source Vaccines Become A Reality For India?

Read Article
People's DemocracyJune 7, 2020

Open Source Covid Movement: A Non-Capitalist Alternative to Covid Control

Originally published in Malayalam by Dr. B. Ekbal on 22 May 2020; translated into more than ten languages.

Read Article
Pills beside a medicine bottle
Fast Company
April 30, 2020

How open-source medicine could prepare us for the next pandemic

The old drug discovery system was built to benefit shareholders, not patients. But a new, Linux-like platform could transform the way medicine is developed—and energize the race against COVID-19.

Read Article
BBCDecember 22, 2017

We should own our own livelihood and our own dream

Read Article
Scientists working in a laboratory
The Guardian
April 19, 2017

Why open source pharma is the path to both new and cheaper medicines

Read Article
The LancetMay 14, 2016

Can open-source drug development deliver?

Read Article
The EconomistNovember 28, 2015

Billion-dollar babies

Read Article
The Hindu BusinessLineSeptember 29, 2015

Tata Trusts Support OSPF — the 'Linux for drugs'

The initiative borrows from the Linux model, where it is end-to-end open source, and publically funded. So data is made public at every stage for academics, non-governmental organisations, communities or drug companies to get involved and work on a research lead.

Read Article
SlashdotSeptember 5, 2015

What is open source pharma (and why should you care)?

Read Article
ForbesOctober 16, 2014

Beyond Heroism and Denial: How to Fortify our Response to Ebola

Read Article
“I call on all countries, companies, and research institutions to support open data, open science, and open collaboration so all people can enjoy the benefits of science and research.”
Dr. Tedros Ghebreyesus
Director-General, World Health Organization

Media Enquiries

For interviews, expert comment, or press materials, get in touch through our contact form and we’ll connect you with the right people at Open Source Pharma Foundation.

Contact the Team

Join the Movement. Shape the Future of Open Science.

Help advance open science through AI, global collaboration, and accessible healthcare. Volunteer or donate to make a lasting impact.